Sandra Trompezinski
Sandra Trompezinski has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alejandra Piegari Feliu
CIREC LATAM Buenos Aires Argentina
1 shared publicationArnaud Fontbonne
Institut NAOS des Sciences de la Vie Aix‐en‐Provence France
1 shared publication- Arnaud Fontbonne
Institut NAOS Aix‐en‐Provence France
1 shared publication Audrey Gerstel
NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
1 shared publication- Benoît Cadars
NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
1 shared publication - Elodie Prestat‐Marquis
NAOS Ecobiology Company (Bioderma) Aix‐en‐Provence France
1 shared publication
Latest Publications
- Open Access
- 29 May 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (6)
Evaluation of a Dermocosmetic Serum for Managing Hyperpigmentation Disorders in Phototypes IV ‐ VI Individuals From South Africa and Argentina
Background: Hyperpigmentation disorders are a distressing condition, especially for individuals with skin of color who are at higher risk. Often treated topically, a significant advancement in this field was Kligman's depigmenting trio, inhibiting melanogenesis, providing anti‐inflammatory benefits, and promoting epidermal renewal. Aims: Evaluate a serum (Pigmentbio C‐Concentrate, NAOS, LABORATOIRE BIODERMA), inspired by Kligman's trio's mode of action. Methods: Clinical studies were conducted on phototype IV–VI subjects in South Africa and Argentina. Subjects applied the serum nightly for 84 days. Clinical assessments were performed on days 0, 28, 56, and 84, with instrumental skin color evaluation in Argentina. The burden of hyperpigmentation was assessed at baseline and D84 using the Dermatology Life Quality Index (DLQI, South Africa) or the Melasma Quality of Life Questionnaire (MELASQoL, Argentina). Results: In South Africa, clinical assessments showed a significant reduction in the number (−15%), intensity (−32%), and size (−13%) of hyperpigmented elements within 28 days. The Argentinian study similarly reported significantly decreased intensity (−18%), visibility (−32%), and contrast (−29%) of hyperpigmented elements on D28, alongside improved complexion homogeneity (+17%). In both studies, maximum improvements occurred on D84. These results were supported by instrumental assessments of skin luminance and pigmentation of hyperpigmented areas (L*: +5%, ITA°: +53% on D84), and color difference between hyperpigmented and non‐hyperpigmented areas (∆E: −16% on D84). Participants also reported a reduced burden of hyperpigmentation (DLQI: −92%; MELASQoL: −33%). Conclusion: Replicating the complementary activities of Kligman's trio, the serum effectively reduces hyperpigmentation and its associated burden in individuals with darker phototypes.
- 29 May 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (6)
Open AccessEvaluation of a Dermocosmetic Serum for Managing Hyperpigmentation Disorders in Phototypes IV ‐ VI Individuals From South Africa and Argentina
Background: Hyperpigmentation disorders are a distressing condition, especially for individuals with skin of color who are at higher risk. Often treated topically, a significant advancement in this field was Kligman's depigmenting trio, inhibiting melanogenesis, providing anti‐inflammatory benefits, and promoting epidermal renewal. Aims: Evaluate a serum (Pigmentbio C‐Concentrate, NAOS, LABORATOIRE BIODERMA), inspired by Kligman's trio's mode of action. Methods: Clinical studies were conducted on phototype IV–VI subjects in South Africa and Argentina. Subjects applied the serum nightly for 84 days. Clinical assessments were performed on days 0, 28, 56, and 84, with instrumental skin color evaluation in Argentina. The burden of hyperpigmentation was assessed at baseline and D84 using the Dermatology Life Quality Index (DLQI, South Africa) or the Melasma Quality of Life Questionnaire (MELASQoL, Argentina). Results: In South Africa, clinical assessments showed a significant reduction in the number (−15%), intensity (−32%), and size (−13%) of hyperpigmented elements within 28 days. The Argentinian study similarly reported significantly decreased intensity (−18%), visibility (−32%), and contrast (−29%) of hyperpigmented elements on D28, alongside improved complexion homogeneity (+17%). In both studies, maximum improvements occurred on D84. These results were supported by instrumental assessments of skin luminance and pigmentation of hyperpigmented areas (L*: +5%, ITA°: +53% on D84), and color difference between hyperpigmented and non‐hyperpigmented areas (∆E: −16% on D84). Participants also reported a reduced burden of hyperpigmentation (DLQI: −92%; MELASQoL: −33%). Conclusion: Replicating the complementary activities of Kligman's trio, the serum effectively reduces hyperpigmentation and its associated burden in individuals with darker phototypes.
- Open Access
- 21 October 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (2) , 327-338
Antioxidative and chaperone‐like activities of a bacterioruberin‐rich extract: An innovative approach to protect the skin proteome
Objective: Oxidative stress and its induced protein alterations are instrumental in the early onset and progression of ageing. To protect the skin proteome, we evaluated the extract of a bacterium isolated from snowflakes ( Arthrobacter agilis ). This Arthrobacter agilis extract (AAE) has been found to be rich in bacterioruberins, C‐50 unsaturated carotenoids with potent antioxidative properties. Methods: The Arthrobacter agilis extract (AAE), having protective effect against oxidative, saline, and heat stresses, was evaluated in tubo. Protection against protein carbonylation was assessed in human primary keratinocytes and skin explants subjected to various stresses. The impact of an AAE‐containing cream on protein carbonylation was analysed on the face of 23 smokers after 28 days. Results: In tubo, AAE protects alkaline phosphatase against oxidative and heat stresses, increasing the temperature at which BSA is denatured. It also partially prevented elastin aggregation induced by a salt stress. In human primary keratinocytes exposed to UV, particulate matter (PM), or blue light, AAE reduced protein carbonylation, a marker of oxidative stress in the proteome. When formulated in creams, topical applications prevent protein carbonylation in the epidermis and dermis of skin explants co‐exposed to UV and PM. Furthermore, after 28 days of application, protein carbonylation was reduced in the upper skin layers of smokers. Conclusions: AAE protects the proteome against oxidative stress via a dual mode of action: antioxidant and chaperone‐like activities (as demonstrated by protection against heat and salt). AAE is a promising age‐management compound that safeguards the fragile skin ecosystem in an ecobiological approach, protecting the effectors of healthy skin functioning and reinforcing natural defences when overwhelmed.
- 21 October 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 48 (2) , 327-338
Open AccessAntioxidative and chaperone‐like activities of a bacterioruberin‐rich extract: An innovative approach to protect the skin proteome
Objective: Oxidative stress and its induced protein alterations are instrumental in the early onset and progression of ageing. To protect the skin proteome, we evaluated the extract of a bacterium isolated from snowflakes ( Arthrobacter agilis ). This Arthrobacter agilis extract (AAE) has been found to be rich in bacterioruberins, C‐50 unsaturated carotenoids with potent antioxidative properties. Methods: The Arthrobacter agilis extract (AAE), having protective effect against oxidative, saline, and heat stresses, was evaluated in tubo. Protection against protein carbonylation was assessed in human primary keratinocytes and skin explants subjected to various stresses. The impact of an AAE‐containing cream on protein carbonylation was analysed on the face of 23 smokers after 28 days. Results: In tubo, AAE protects alkaline phosphatase against oxidative and heat stresses, increasing the temperature at which BSA is denatured. It also partially prevented elastin aggregation induced by a salt stress. In human primary keratinocytes exposed to UV, particulate matter (PM), or blue light, AAE reduced protein carbonylation, a marker of oxidative stress in the proteome. When formulated in creams, topical applications prevent protein carbonylation in the epidermis and dermis of skin explants co‐exposed to UV and PM. Furthermore, after 28 days of application, protein carbonylation was reduced in the upper skin layers of smokers. Conclusions: AAE protects the proteome against oxidative stress via a dual mode of action: antioxidant and chaperone‐like activities (as demonstrated by protection against heat and salt). AAE is a promising age‐management compound that safeguards the fragile skin ecosystem in an ecobiological approach, protecting the effectors of healthy skin functioning and reinforcing natural defences when overwhelmed.